Latest Business Development News

Triton Minerals has executed a key agreement advancing the sale of 70% of its Mozambique graphite assets and completed initial drilling at its Aucu gold-copper project, positioning the company for growth amid stable operating conditions.

Thrive Tribe Technologies reported a $186,000 net operating cash outflow in Q2 FY26, offset by a $300,000 equity raise to fund growth initiatives and operational expansion.

Eminence Minerals reports strong near-surface rare earth results in Brazil and advances a judicial review over heritage site decisions in Western Australia, while appointing new leadership to drive growth.

Leeuwin Metals has delivered a maiden Mineral Resource Estimate of over 340,000 ounces at its Marda Gold Project, marking a significant milestone less than a year after acquisition. Strong drilling results at Evanston underpin promising resource growth prospects.

Altair Minerals has raised $13 million to fund a major drilling campaign at its Greater Oko Project in Guyana, aiming to explore one of the world's most promising and consolidated gold belts.

Metgasco has secured shareholder approval to sell its 25% interests in the Odin and Vali gas fields for $5.9 million, marking a strategic exit from its core assets amid declining production and ongoing liquidity challenges.

ACDC Metals has reported encouraging mineralogy results from its Goschen Central Rare Earth Elements project, reinforcing its strategic value amid rising geopolitical interest. The company maintains a solid cash balance to support ongoing development and exploration activities.

Estrella Resources has reported multiple high-grade manganese intersections at its Ira Miri project, including assays up to 58% manganese, and received regulatory approval for a 30,000-tonne bulk sample extraction. Concurrently, drilling at the Werumata limestone project has been completed with assay results pending.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

Synertec Corporation Limited has reported a robust 25% increase in revenue for FY26 Q2 alongside a significant turnaround to positive operating cashflow, underpinned by strong project pipelines and strategic partnerships.

LCL Resources reported promising high-grade gold-copper-silver assays from trenching in Papua New Guinea and is actively pursuing lower-risk jurisdiction assets while advancing its Colombian option agreement.